Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2026-01-16 @ 9:33 AM
Study NCT ID:
NCT02860650
Status:
COMPLETED
Last Update Posted:
2018-02-05
First Post:
2016-08-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy Adults
Sponsor:
Janssen Vaccines & Prevention B.V.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-04
First Submit QC Date:
None
Study First Post Date:
2016-08-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-02
Last Update Post Date:
2018-02-05
Last Update Post Date Type:
ACTUAL